文献速递血栓与止血

应用全外显子组测序指导斯堪的纳维亚厄勒海峡地区罕见遗传性出血性疾病患者的功能检测与诊断

Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, Scandinavia.
PubMed 文献 · Br J Haematol · 2017-07-27

研究纳入156例出血评估工具评分显著的患者,其中三分之一患血小板减少症,对87个出血相关基因行全外显子组测序并按五级方案分类变异。共检出353个胚系变异,8例(5%)携带已知致病性变异;经计算分析、孟德尔遗传模式过滤及靶向功能检测,34%(20/59)被归类为新发4级或5级变异。血小板减少症患者中4级或5级变异检出率为30%(14/47),血小板计数正常者为11%(12/109)(P<0·01)。

要点

  • 全外显子组测序可 upfront 指导罕见遗传性出血性疾病的靶向功能检测与诊断。
  • 血小板减少症患者4级或5级变异检出率30%(14/47)vs 血小板计数正常者11%(12/109)(P<0·01)。
  • 59个预测有临床意义的变异中,34%(20/59)经靶向功能检测被定为新发4级或5级变异。

核心结论

  • 全外显子组测序联合靶向功能检测可帮助解决罕见遗传性出血性疾病的诊断困境,持续优化其诊断流程具有很大益处。

研究设计与样本

  • 研究纳入156例出血评估工具评分显著的患者,其中三分之一患血小板减少症,对87个与出血遗传易感性特异性相关的基因行全外显子组测序,变异按五级方案分类。

主要发现

  • 共检出353个胚系变异,8例(5%)携带已知致病性变异。
  • 345个既往未知变异中,计算分析预测99个有显著性;按孟德尔遗传模式进一步过滤后,59个变异被预测有临床意义。
  • 59个变异中34%(20/59)经靶向功能检测被定为新发4级或5级变异。
  • 血小板减少症患者中4级或5级变异检出率为30%(14/47),血小板计数正常者为11%(12/109)(P<0·01)。

临床怎么用

  • 作者认为,遗传性出血性疾病诊断具有重大临床影响,本文详述的基因检测使患者摆脱了诊断困境。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rare inherited bleeding disorders (IBD) are a common cause of bleeding tendency. To ensure a correct diagnosis, specialized laboratory analyses are necessary. This study reports the results of an upfront diagnostic strategy using targeted whole exome sequencing. In total, 156 patients with a significant bleeding assessment tool score participated in the study, of which a third had thrombocytopenia. Eighty-seven genes specifically associated with genetic predisposition to bleeding were analysed by whole exome sequencing. Variants were classified according to the five-tier scheme. We identified 353 germline variants. Eight patients (5%) harboured a known pathogenic variant. Of the 345 previously unknown variants, computational analyses predicted 99 to be significant. Further filtration according to the Mendelian inheritance pattern, resulted in 59 variants being predicted to be clinically significant. Moreover, 34% (20/59) were assigned as novel class 4 or 5 variants upon targeted functional testing. A class 4 or 5 variant was identified in 30% of patients with thrombocytopenia (14/47) versus 11% of patients with a normal platelet count (12/109) (P < 0·01). An IBD diagnosis has a major clinical impact. The genetic investigations detailed here extricated our patients from a diagnostic conundrum, thus demonstrating that continuous optimization of the diagnostic work-up of IBD is of great benefit.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Leinøe E, Zetterberg E, Kinalis S, et al. Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, Scandinavia. Br J Haematol. 2017. PMID: 28748566. doi:10.1111/bjh.14863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。